In the constant pursuit of effective weight loss solutions, the pharmaceutical world has witnessed the emergence of GLP-1 receptor agonists, a class of medications primarily designed for managing type 2 diabetes. However, their remarkable side effect - significant weight loss - has drawn attention, prompting us to delve into the details of GLP-1 medications like semaglutide (also known as Wegovy® or Ozempic®). At Dakota PrecisionRx Labs we're at the forefront of customized weight loss solutions and this blog aims to unravel the potential of GLP-1 drugs in achieving lasting weight loss.
How do GLP-1 Medications work?
Weight loss has been a struggle for many, and traditional medications have limitations. GLP-1 agonists, such as semaglutide, work by mimicking the naturally produced hormone GLP-1 (glucagon-like peptide 1).
Originally developed for diabetes, their unexpected impact on appetite suppression and weight loss has shifted the narrative. Medications like semaglutide work to help you lose weight by stimulating insulin secretion, suppressing hunger and increasing feelings of fullness, offering hope to those seeking effective weight management.
When searching for weight loss solutions, it's vitally important to combine any medication program like semaglutide while working closely with a healthcare provider to address the root cause of your health concerns and work to improve your overall wellness for lasting weight loss results.
Weight Loss Injections, and Innovating Solutions
Semaglutide and other GLP-1 medications have gained traction as injections administered daily or weekly. One significant stride towards innovation is the potential development of sublingual semaglutide, providing a needle-free alternative for those averse to injections or seeking a more convenient and customized option.
How effective are GLP-1 medications for Weight Loss?
Studies reveal the impressive effectiveness of GLP-1 medications in weight loss. These medications offer promising results such as 5-10% weight loss when paired with lifestyle changes. The sources below are a great start to your own research and our pharmacists are here to help connect you and your doctor with current research to learn more.
-
Singh G, Krauthamer M, Bjalme-Evans M. Wegovy (Semaglutide): A New Weight Loss Drug for Chronic Weight Management. Journal of Investigative Medicine. 2022;70(1):5-13. doi:10.1136/jim-2021-001952
-
Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414–1425. doi:10.1001/jama.2021.3224
-
Ahrén B, Atkin SL, Charpentier G, et al. Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials. Diabetes Obes Metab. 2018; 20: 2210–2219. https://doi.org/10.1111/dom.13353
Risks and Benefits of Semaglutide and other GLP-1 Medications
While the benefits of GLP-1 medications are substantial, it's crucial to address the risks. Common side effects possible are nausea and vomiting. More severe but rare complications may include pancreatitis. Understanding these nuances is vital and it's important to work closely with your pharmacist and healthcare provider for guidance, minimizing the risks, while maximizing your benefits.
Semaglutide and other GLP-1 medications present a promising avenue for those seeking effective and lasting weight loss solutions. Dakota PrecisionRx Labs is committed to being your partner in this journey, offering a customizable approach to your weight management medication plan. Consult with us to explore the potential of injection-free GLP-1 medications tailored to your unique needs and health profile.